This article was originally published on ETFTrends.com.
Biotechs ETFs created some heat yesterday as The SPDR S&P Biotech ETF and the iShares Nasdaq Biotechnology ETF, two popular exchange-traded funds tracking the biotechnology space, jumped on Monday after Pfizer, the largest drugmaker in the U.S., said it would buy Array BioPharma for over $10 billion. The iShares Nasdaq Biotechnology ETF (IBB) is on pace for its fourth positive day of […]
Continue Reading Below
